News for IceCure Medical Ltd (ICCM.TA)

IceCure Medical (ICCM) has received a Notice of Allowance for its 'Cryogen Flow Control' patent application from the United States Patent and Trademark Office.

Release Date: May 28, 2025For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Icecure Medical L

Refinitiv StreetEvents Event TranscriptE D I T E D V E R S I O NICCM.OQ - Icecure Medical LtdQ1 2025 Icecure Medical Ltd Earnings CallMay 28, 2025 / 02:00PM G

Operator: Ladies and gentlemen, thank you for standing by. The call will begin shortly. Good morning, and thank you for standing by. Currently, all the participants are in a listen-only mode.

IceCure Medical Ltd (NASDAQ:ICCM) Q1 2025 Earnings Conference Call May 28, 2025 10:00 AM ETCompany ParticipantsMichael Polyviou - IREyal Shamir - CEORonen...

Icecure Medical Ltd (ICCM) is set to release its Q1 2025 earnings on May 28, 2025. The consensus estimate for Q1 2025 revenue is $0.75 million, and the earnings

PR NewswireCAESAREA, Israel, May 6, 2025 Breast surgeons expressed strong interest in participating in IceCure's planned post-market study for ProSense® i

IceCure Medical (ICCM) received strong interest from breast surgeons at the ASBrS 2025 Annual Meeting. The FDA has requested a post-market study for Pro

IceCure Medical (ICCM) has recently engaged in discussions with the FDA's Center for Devices and Radiological Health concerning its De Novo marketing authorizat

FDA guides IceCure Medical's (ICCM) ProSense® cryoablation system towards marketing authorization for early-stage breast cancer treatment in women aged 70

Operator: Good morning and thank you for standing by. Currently, all the participants are in a listen-only mode. After management's discussion, there will be a question and answer session.

IceCure Medical Ltd (NASDAQ:ICCM) Q4 2024 Earnings Conference Call March 27, 2025 10:00 AM ETCompany ParticipantsMichael Polyviou - Investor RelationsEyal...

PR NewswireCAESAREA, Israel, March 20, 2025 IceCure working in close collaboration with FDA towards De Novo decisionCAESAREA, Israel, March 20, 2025 /PRNew

PR NewswireCAESAREA, Israel, March 18, 2025 IceCure exhibited at the prestigious event in Vienna, Austria attended by oncologists, breast surgeonsAn abstra

PR NewswireCAESAREA, Israel, March 17, 2025 This latest IP win rounds out protection for the cryogenic pump in major global market following grants for the

PR NewswireCAESAREA, Israel, March 10, 2025 Independent study published in Gland Surgery and conducted at Kameda Medical Center in Japan by ProSense® user

PR NewswireCAESAREA, Israel, Feb. 24, 2025 Application covering a wide range of indications is in line with trends in de-escalation of surgery and growth i

PR NewswireCAESAREA, Israel, Jan. 27, 2025 Seeks to expand regulatory approval in China where IceSense3 has already been approvedCAESAREA, Israel, Jan. 27,

PR NewswireCAESAREA, Israel, Jan. 6, 2025 CAESAREA, Israel, Jan. 6, 2025 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medical"